Literature DB >> 19239163

Does taurine deficiency cause metabolic bone disease and rickets in polar bear cubs raised in captivity?

Russell W Chesney1, Gail E Hedberg, Quinton R Rogers, Ellen S Dierenfeld, Bruce E Hollis, Andrew Derocher, Magnus Andersen.   

Abstract

Rickets and fractures have been reported in captive polar bears. Taurine (TAU) is key for the conjugation of ursodeoxycholic acid (UDCA), a bile acid unique to bears. Since TAU-conjugated UDCA optimizes fat and fat-soluble vitamin absorption, we asked if TAU deficiency could cause vitamin D malabsorption and lead to metabolic bone disease in captive polar bears. We measured TAU levels in plasma (P) and whole blood (WB) from captive and free-ranging cubs and adults, and vitamin D3 and TAU concentrations in milk samples from lactating sows. Plasma and WB TAU levels were significantly higher in cubs vs captive and free-ranging adult bears. Vitamin D in polar bear milk was 649.2 +/- 569.2 IU/L, similar to that found in formula. The amount of TAU in polar bear milk is 3166.4 +/- 771 nmol/ml, 26-fold higher than in formula. Levels of vitamin D in bear milk and formula as well as in plasma do not indicate classical nutritional vitamin D deficiency. Higher dietary intake of TAU by free-ranging cubs may influence bile acid conjugation and improve vitamin D absorption.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19239163     DOI: 10.1007/978-0-387-75681-3_33

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

Review 1.  Metabolic bone disease in lion cubs at the London Zoo in 1889: the original animal model of rickets.

Authors:  Russell W Chesney; Gail Hedberg
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

2.  Metabolic changes in summer active and anuric hibernating free-ranging brown bears (Ursus arctos).

Authors:  Peter Stenvinkel; Ole Fröbert; Björn Anderstam; Fredrik Palm; Monica Eriksson; Ann-Christin Bragfors-Helin; Abdul Rashid Qureshi; Tobias Larsson; Andrea Friebe; Andreas Zedrosser; Johan Josefsson; My Svensson; Berolla Sahdo; Lise Bankir; Richard J Johnson
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.